Livzon Pharmaceutical Group, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
3,056.00
3,031.00
2,568.00
2,638.00
2,659.00
2,795.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
65.00
-142.00
17.00
-144.00
-805.00
-412.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
3,447.00
3,247.00
3,750.00
3,376.00
2,411.00
2,478.00
Cash Flow from Investing Activities
-4,084.00
-701.00
-858.00
-1,582.00
-2,407.00
-571.00
Cash Flow from Financing Activities
-2,919.00
-2,727.00
-1,915.00
-837.00
-955.00
-587.00
Net Cash Inflow / Outflow
-3,662.00
-171.00
998.00
1,101.00
-996.00
1,233.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-106.00
9.00
22.00
145.00
-44.00
-86.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Livzon Pharmaceutical Group, Inc.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
3056.22323348007
7.74783496044244
3,049.00
39346.16%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
65.5922623891756
-94.8567520968837
159.00
169.15%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
3447.67854481235
25.0850255648143
3,422.00
13643.97%
Cash Flow from Investing Activities
-4084.5309920578
-297.210376176423
-3,787.00
-1274.29%
Cash Flow from Financing Activities
-2919.66988187557
1277.76049134787
-4,196.00
-328.50%
Net Cash Inflow / Outflow
-3662.92842223468
1005.40305273493
-4,667.00
-464.32%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-106.406093113667
-0.232088001334642
-106.00
-45747.30%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 6.17% vs -13.42% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
3,447.68
3,247.35
6.17%






